P1094: SAFETY AND EFFICACY OF ACALABRUTINIB, BENDAMUSTINE, AND RITUXIMAB IN PATIENTS WITH TREATMENT-NAIVE OR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: PHASE IB TRIAL - Tycel Phillips; Michael Wang; Tadeusz Robak; David Gallinson; Don Stevens; Krish Patel; Safaa Ramadan; Chuan-Chaun Wun; Wojciech Jurczak; Stephen D. Smith (HemaSphere, 2023)